ZW-171

N/A

Report date: 2026/03/19 17:18:13

Base Information

Drug NameZW-171

Drug Alias NameZW-171

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-MesothelinCD3 T-cell engagers

TargetsMesothelinT cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesGermany +[5]

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Develop Information

Active CompaniesZymeworks Inc

Inactive CompaniesZymeworks BC Inc

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A